Demyelination after anti-TNF therapy: Who is at risk?

Bibliographic Details
Main Authors: Williams, I, Uhlig, HH
Format: Journal article
Language:English
Published: European Crohn's and Colitis Organisation 2020
_version_ 1797091788812451840
author Williams, I
Uhlig, HH
author_facet Williams, I
Uhlig, HH
author_sort Williams, I
collection OXFORD
description
first_indexed 2024-03-07T03:37:32Z
format Journal article
id oxford-uuid:bccb9835-7ed3-45a4-bd07-e1880d8ede3b
institution University of Oxford
language English
last_indexed 2024-03-07T03:37:32Z
publishDate 2020
publisher European Crohn's and Colitis Organisation
record_format dspace
spelling oxford-uuid:bccb9835-7ed3-45a4-bd07-e1880d8ede3b2022-03-27T05:27:03ZDemyelination after anti-TNF therapy: Who is at risk?Journal articlehttp://purl.org/coar/resource_type/c_b239uuid:bccb9835-7ed3-45a4-bd07-e1880d8ede3bEnglishSymplectic ElementsEuropean Crohn's and Colitis Organisation2020Williams, IUhlig, HH
spellingShingle Williams, I
Uhlig, HH
Demyelination after anti-TNF therapy: Who is at risk?
title Demyelination after anti-TNF therapy: Who is at risk?
title_full Demyelination after anti-TNF therapy: Who is at risk?
title_fullStr Demyelination after anti-TNF therapy: Who is at risk?
title_full_unstemmed Demyelination after anti-TNF therapy: Who is at risk?
title_short Demyelination after anti-TNF therapy: Who is at risk?
title_sort demyelination after anti tnf therapy who is at risk
work_keys_str_mv AT williamsi demyelinationafterantitnftherapywhoisatrisk
AT uhlighh demyelinationafterantitnftherapywhoisatrisk